FFO ACCELERATES IN 2Q26 AND GROWS 12%
Posted inNews

FFO ACCELERATES IN 2Q26 AND GROWS 12%

RIO DE JANEIRO, Aug. 6, 2026 /PRNewswire/ -- ALLOS S.A. (B3: ALOS3), the most innovative experience, entertainment, services, lifestyle and shopping platform in Latin America, announces its results for the second quarter of 2026 (2Q26). At the end…
Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China
Posted inMinimal

Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China

SAN FRANCISCO and SUZHOU, China, Aug. 5, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and…